TY - JOUR T1 - Advancing Germany’s new global health strategy JF - BMJ Global Health DO - 10.1136/bmjgh-2018-001140 VL - 3 IS - 6 SP - e001140 AU - Jan M Stratil AU - Peter von Philipsborn AU - Georg Marckmann AU - Lisa M Pfadenhauer AU - Hajo Zeeb AU - Eva Annette Rehfuess Y1 - 2018/12/01 UR - http://gh.bmj.com/content/3/6/e001140.abstract N2 - Summary boxReacting to a rapidly changing global health landscape, the German government has initiated the development of a new global health strategy, to be published in 2019.As there is no universal ‘right’ decision on how to tackle the plethora of global health challenges with the available resources, the German government will need to reflect on how decisions can be made and multiple strategic considerations and interests balanced.With strengthening its commitment to fair, transparent and participatory decision-making processes in the development and implementation of its new global health strategy, Germany can ensure buy-in from German society at large and contribute to shaping the way global health is practised in the coming decades.During the past decade, Germany has increasingly taken on a leadership role in global health.1 Facing the changing global political landscape, the German government under Chancellor Angela Merkel initiated a process to develop a new global health strategy in June 2018. Following a public kick-off meeting, five stakeholder groups—representatives of the civil society (non-governmental organisations), think tanks, private sector, academia and youth organisations—were invited to provide input through position papers. These are expected to be considered in interministerial discussions on the new strategy, which is scheduled to be adopted by the end of 2019.We welcome this new initiative, which is an opportunity for Germany to extend its current global health strategy, adopted in 2013,2 and to further define and strengthen its role in global health. In doing so, Germany has to strike a balance between underlying diverging strategic considerations, as the decisions made in the previous global health strategy have been subject to criticism (eg, different perceptions regarding the role that the German healthcare industry should play).3–5 Such strategic considerations may include (1) paying tribute to Germany’s role within the international community and global … ER -